Longitudinal follow-up of spirometry parameters in patients with COPD during pulmonary rehabilitation

<bold>Background:</bold> Spirometry is pivotal in the diagnosis and classification of COPD. There is limited data regarding variation in daily spirometry measurements in COPD. <bold>Objectives:</bold> This study investigated daily variation per week in spirometry parameters in patients with COPD during an 8-week inpatient pulmonary rehabilitation (PR) programme. <bold>Methods:</bold> Data of the first 30 participants of the ongoing “early diagnostic bioMARKers in Exacerbations of COPD” (MARKED) study (<ext-link>NCT05315674</ext-link>) in Ciro (Horn, The Netherlands) were analyzed. Spirometries were performed five days a week (Monday-Friday), during eight weeks. Values of the forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio and peak expiratory flow (PEF) were captured. To test variations of daily spirometry results within individuals per week, during the eight-week PR period, the Friedman test and the post-hoc 2-way ANOVA analysis were performed, excluding dropouts. <bold>Results:</bold> At baseline, patients (60% males, aged 69±7.3 years) had an average of FEV1: 35.9±16.5% pred, FVC: 83.0±21.5% pred, FEV1/FVC: 33.6±10.4% and PEF: 57.4±15.8% pred. No significant differences in spirometry measurements were observed within individuals per week, during 8-week PR. Nine patients (30%) dropped out mainly due to the burden of daily spirometry (89%). <bold>Conclusions:</bold> This study demonstrated no significant differences in daily spirometry measurements within patients with COPD on a weekly basis during eight-weeks of PR. Results of the MARKED and other studies are needed to validate these findings.

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa3064
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longitudinal follow-up of spirometry parameters in patients with COPD during pulmonary rehabilitation

Sarah Houben‐Wilke, Kristoffer Ostridge, Frits M.E. Franssen, Martijn A. Spruit et al.
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Longitudinal follow-up of spirometry parameters in patients with COPD during pulmonary rehabilitation

Sarah Houben‐Wilke, Kristoffer Ostridge, Frits M.E. Franssen, Martijn A. Spruit, Kiki Waeijen-Smit, Victoria Godfrey, Daphne Peerlings, Antonio DiGiandomenico, Sami O. Simons, Sander M. J. van Kuijk, Josh Woozley
article en

Abstract

<bold>Background:</bold> Spirometry is pivotal in the diagnosis and classification of COPD. There is limited data regarding variation in daily spirometry measurements in COPD. <bold>Objectives:</bold> This study investigated daily variation per week in spirometry parameters in patients with COPD during an 8-week inpatient pulmonary rehabilitation (PR) programme. <bold>Methods:</bold> Data of the first 30 participants of the ongoing “early diagnostic bioMARKers in Exacerbations of COPD” (MARKED) study (<ext-link>NCT05315674</ext-link>) in Ciro (Horn, The Netherlands) were analyzed. Spirometries were performed five days a week (Monday-Friday), during eight weeks. Values of the forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio and peak expiratory flow (PEF) were captured. To test variations of daily spirometry results within individuals per week, during the eight-week PR period, the Friedman test and the post-hoc 2-way ANOVA analysis were performed, excluding dropouts. <bold>Results:</bold> At baseline, patients (60% males, aged 69±7.3 years) had an average of FEV1: 35.9±16.5% pred, FVC: 83.0±21.5% pred, FEV1/FVC: 33.6±10.4% and PEF: 57.4±15.8% pred. No significant differences in spirometry measurements were observed within individuals per week, during 8-week PR. Nine patients (30%) dropped out mainly due to the burden of daily spirometry (89%). <bold>Conclusions:</bold> This study demonstrated no significant differences in daily spirometry measurements within patients with COPD on a weekly basis during eight-weeks of PR. Results of the MARKED and other studies are needed to validate these findings.

Maastricht University Medical Centre (NL), Maastricht University (NL), AstraZeneca (Switzerland) (CH), AstraZeneca (Finland) (FI), Ciro (NL), AstraZeneca (Germany) (DE)
Openalex Percentile: Top 63%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.